Cancer BiologybioRxiv
MET Inhibitor Capmatinib Radiosensitizes MET Exon 14-Mutated and MET-Amplified Non-Small Cell Lung Cancer
S. Ramesh, A. Cifci, S. Javeri…·A. M. Baschnagel
This study shows that capmatinib radiosensitizes MET exon 14-mutated and MET-amplified NSCLC cells and tumors, inhibiting DNA repair and reducing tumor growth.
DOI 10.1016/j.ijrobp.2023.11.013